Postdoctoral Research Fellow – Pharmaceutics (Harvard University)
Specialist in Lipid Nanoparticle Drug Delivery & mRNA Formulation

Dr. Muhammad Muzamil Khan is a highly accomplished pharmaceutical scientist with a PhD in Pharmaceutics and a post-doctoral fellowship from Harvard University. His expertise centers on the design and formulation of Lipid Nanoparticles (LNPs) for mRNA delivery, with a special focus on optimizing LNP systems to enhance immune response and support the development of modern vaccines, including bacterial vaccines.

Dr. Muzamil previously worked at the Center of Nanomedicine, Brigham and Women’s Hospital, Harvard Medical School, where he contributed to the development of LNP-based platforms for cancer immunotherapy under the prestigious Fulbright Scholarship awarded by the U.S. Department of State.

During his PhD, he also completed part of his research at Northeastern University, Boston, where he developed hypoxia-sensitive drug delivery systems targeting tumor cells.

As part of the AllerFreeLifestyle Medical Review Board, Dr. Muzamil reviews content related to drug delivery systems, pharmaceutical technologies, vaccine mechanisms, immunological responses, and emerging therapeutic platforms. His advanced scientific background ensures our content remains research-driven, accurate, and aligned with global advancements in pharmaceutics and nanomedicine.